Andere Sprachen MOA Life Plus Co. Ltd.

Aktien

A142760

KR7142760008

A142760

Schlusskurs Korea S.E. Andere Börsenplätze 00:00:00 14.05.2024			% 5 Tage	% 1. Jan.
2 340 ^KRW	+2,86 %		-11,36 %	+9,86 %

28.03.	Youngchul Park hat die Übernahme von 24,43% der Anteile an der BL Pharmtech Corp. (KOSDAQ : A065170) von der Bioleaders Corporation (KOSDAQ:A142760) abgeschlossen.	CI
28.03.	Moadata Co., Ltd. (KOSDAQ:A288980) hat die Übernahme von 6,95% der Anteile an der Bioleaders Corporation (KOSDAQ:A142760) von Youngchul Park abgeschlossen.	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Bioleaders Corporation announced that it has received KRW 10 billion in funding from Moadata Co., Ltd.	15.04.
Bioleaders Corporation announced that it has received KRW 15 billion in funding	29.03.
Youngchul Park completed the acquisition of 24.43% stake in BL Pharmtech Corp. (KOSDAQ : A065170) from Bioleaders Corporation.	28.03.
Moadata Co., Ltd. completed the acquisition of 6.95% stake in Bioleaders Corporation from Youngchul Park.	28.03.
Bioleaders Corporation announced that it expects to receive KRW 15 billion in funding	14.03.
Moadata Co., Ltd. agreed to acquire a 6.95% stake in Bioleaders Corporation from Youngchul Park for KRW 15.3 billion	13.03.
Bioleaders Corporation announced that it expects to receive KRW 10 billion in funding from Moadata Co., Ltd.	12.03.
Youngchul Park agreed to acquire 24.43% stake in BL Pharmtech Corp. (KOSDAQ : A065170) from Bioleaders Corporation for KRW 9.3 billion.	12.03.
Bioleaders Corporation announced that it has received KRW 2 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.	02.01.
An unknown buyer agreed to acquire 20.25052% stake in Anyone F&C Co., Ltd. from Bioleaders Corporation for KRW9.9 billion.	29.12.
Bioleaders Corporation announced that it expects to receive KRW 2 billion in funding from Kwang Dong Pharmaceutical Co., Ltd.	29.12.
Bioleaders Corporation(KOSDAQ:A142760) dropped from S&P Global BMI Index	18.09.23
Bioleaders Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	12.05.23
Next Bt Co., Ltd. announced that it has received KRW 6 billion in funding from Bioleaders Corporation, Dk Life Science Co., Ltd. and other investors	01.12.21
Bioleaders Corporation announced that it has received KRW 13 billion in funding from Blash Asset Management Co., Ltd, Tiger Asset Management Discretionary Investment Co., Ltd., and other investors	01.12.21
Bioleaders Corporation announced that it has received KRW 8 billion in funding	01.12.21
Bioleaders Corporation announced that it expects to receive KRW 8 billion in funding from Blash Asset Management Co., Ltd, Tiger Asset Management Discretionary Investment Co., Ltd., and other investors	29.11.21
Bioleaders Corporation announced that it expects to receive KRW 8 billion in funding	29.11.21
Next Bt Co., Ltd. announced that it expects to receive KRW 6 billion in funding from Bioleaders Corporation, Dk Life Science Co., Ltd. and other investors	29.11.21
Bioleaders Corporation announced that it has received KRW 13 billion in funding from C-Square Asset Management, A One Asset Management Co., Ltd, Bluetech Asset Management Co., Ltd., Mirae Asset Daewoo Co., Ltd., Investment Arm, DB Financial Investment Co.,Ltd., Investment Arm, Hanyang Securities Co., Ltd., Investment Arm and other investors	18.02.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen MOA Life Plus Co. Ltd.

Aktien

A142760

KR7142760008

A142760

Andere Sprachen

Filter